Erythromycin resistance determinants include Erm methylases, efflux pu
mps, and inactivating enzymes. To distinguish the different mechanisms
of resistance in clinical isolates, PCR primers were designed so that
amplification of the partial gene products could be detected in multi
plex PCRs. This methodology enables the direct sequencing of amplified
PCR products that can be used to compare resistance determinants in c
linical strains. Further, this methodology could be useful in surveill
ance studies of erythromycin-resistant determinants.